Adaptive deep brain stimulation for children with epilepsy
Part of Brain & nervous system, Genetic & congenital clinical trials.
This trial tests a new type of brain stimulation (adaptive deep brain stimulation) that adjusts in real time to stop seizures in children with Lennox-Gastaut syndrome. It's for children who haven't gotten enough help from medications and have frequent drop seizures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 5 and 14 years old.
- Diagnosed with Lennox-Gastaut syndrome (LGS), confirmed by specific EEG patterns and drop seizures for at least 6 months.
- Had at least 10 seizures in the past 4 weeks.
- Tried at least 2 different seizure medications that didn't work well.
- Currently taking at least one seizure medication at a stable dose for 4 weeks.
- Willing to keep the same medications and diet during the study, and track seizures daily.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new brain stimulation device that adjusts treatment based on your sleep patterns to reduce seizures in Lennox-Gastaut syndrome. The device may help people whose seizures haven't been controlled by medications alone.
This study tracks how brain wave patterns change when children and young adults with Lennox-Gastaut Syndrome (a severe seizure disorder) take fenfluramine, a medication that helps reduce drop seizures. Researchers will use EEG (brain wave recordings) to understand how this treatment affects the brain.
This trial compares two types of brain stimulation—deep brain stimulation (DBS) and vagus nerve stimulation (VNS)—to see which works better for epileptic spasms in children with drug-resistant epilepsy. If your child has not responded to two or more seizure medicines, this study might help find a new way to control their spasms.
This trial tests whether deep brain stimulation of a small area in the brain can help reduce seizures that start in the motor part of the brain and do not respond to medication. It may be an option for people who cannot have surgery or whose surgery did not help enough.
This trial studies how adding or using deep brain stimulation devices affects people with epilepsy. It may help researchers understand which outcomes improve when these implanted devices are used.
This trial tests a new way to stimulate parts of the brain involved in movement to reduce seizures in people with epilepsy that is not controlled by medications. It may help if your seizures involve muscle movements like jerking or stiffening.
Hear when a new Lennox Gastaut Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.